Return On Equity	(Apr 30 2026) 2026	(Apr 30 2025) 2025	(Apr 30 2024) 2024	(Apr 30 2023) 2023	(Apr 30 2022) 2022
Y / Y Equity Change	-35.84 %	87.69 %	-61.97 %	-19.16 %	1246.21 %
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	51.18 %	-	-	-

PMCB all Ratios >> Back to PMCB Management Effectiveness >> See Quarterly PMCB Return On Equity

You need to upgrade your Flash Player

Financial Statements
Pharmacyte Biotech Inc 's Equity	$ 33 Millions	Annual PMCB's Balance sheet
Pharmacyte Biotech Inc 's Annual Income	$ -19 Millions	Annual PMCB's Income Statement
Where are PMCB's Income coming from?		Visit PMCB's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.